The long and short of it is that psychedelics aren’t here yet. There are plenty of companies in various stages of development, doing what they can to make various…
Cedarwood
Roadman Investments’ (LITT.V) recent acquisition target CLOV Biopharma (CBP) is continuing its research into the potential commercial uses of cedar leaf oil vapour (CLOV), specifically when it comes to…